Virax Biolabs Group Ltd (VRAX) Non-Current Assets (2022 - 2025)

Virax Biolabs (VRAX) has 4 years of Non-Current Assets data on file, last reported at $1.5 million in Q1 2025.

• In Q1 2025, Non-Current Assets rose 38.92% year-over-year to $1.5 million; the TTM figure through Mar 2025 stood at $1.5 million (up 38.92% YoY), while the FY2025 annual figure was $1.5 million, up 38.92% from the prior year.
• Non-Current Assets grew to $1.5 million in Q1 2025, from $1.1 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $1.5 million in Q1 2025 and bottomed at -$48706.0 in Q1 2022.
• A 4-year average of $691665.5 and a median of $641060.0 in 2023 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2024 — Non-Current Assets jumped 518.67% — and 2025, when it jumped 38.92%.
• Year by year, Non-Current Assets stood at -$48706.0 in 2022, then surged by 466.29% to $178403.0 in 2023, then jumped by 518.67% to $1.1 million in 2024, then jumped by 38.92% to $1.5 million in 2025.
• The last three Non-Current Assets figures came in at $1.5 million (Q1 2025), $1.1 million (Q1 2024), and $178403.0 (Q1 2023), per Business Quant data.

Peer Comparison